Kirchhelle C, Alas Portillo M, Davis M, Doron A, Dreser A, Fortané N, Haddad C, Hinchliffe S, Kariuki S, Lewycka S, Molyneux S, Lozano CM, Mutua E, Okeke IN, Zhang Betancourt M, Clare I R Chandler CIR. The Lancet Microbe 2026, 7(3). doi: 10.1016/j.lanmic.2025.101315
Summary: Despite increasing international attention, antimicrobial resistance (AMR) governance has often neglected social and equity dimensions. The authors of this Personal View report a qualitative stocktake of intended and unintended consequences of the most recent phase of global AMR governance. Despite unprecedented AMR-related action and investment, empirical studies highlight negative consequences of the decontextualised export of high-income governance frameworks and the neglect of upstream antibiotic-sensitive reforms of production, care, and innovation systems. For the next Global Action Plan on AMR, the authors recommend foregrounding equitable interventions; adopting a bottom-up, integrated perspective to incorporate local realities and solutions; and creating robust social sciences and humanities feedback loops for global AMR frameworks.
